Search

Thomas Sweeney Heard

Examiner (ID: 8001, Phone: (571)272-2064 , Office: P/1675 )

Most Active Art Unit
1654
Art Unit(s)
1654, 1675
Total Applications
1286
Issued Applications
710
Pending Applications
90
Abandoned Applications
491

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10961557 [patent_doc_number] => 20140364587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'Dipeptide Comprising a Non-Proteogenic Amino Acid' [patent_app_type] => utility [patent_app_number] => 14/368465 [patent_app_country] => US [patent_app_date] => 2012-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12797 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368465 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/368465
Dipeptide Comprising a Non-Proteogenic Amino Acid Dec 19, 2012 Abandoned
Array ( [id] => 9174956 [patent_doc_number] => 20130316941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'GLUCAGON ANALOGUES' [patent_app_type] => utility [patent_app_number] => 13/720041 [patent_app_country] => US [patent_app_date] => 2012-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12003 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13720041 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/720041
GLUCAGON ANALOGUES Dec 18, 2012 Abandoned
Array ( [id] => 10459519 [patent_doc_number] => 20150344534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-03 [patent_title] => 'OSTEOPONTIN VARIANTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH AND COMPOSITIONS CONTAINING SUCH OSTEOPONTIN VARIANTS' [patent_app_type] => utility [patent_app_number] => 14/363565 [patent_app_country] => US [patent_app_date] => 2012-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14048 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14363565 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/363565
OSTEOPONTIN VARIANTS FOR USE IN SUPPRESSION OR PREVENTION OF TUMOR GROWTH AND COMPOSITIONS CONTAINING SUCH OSTEOPONTIN VARIANTS Dec 6, 2012 Abandoned
Array ( [id] => 8768240 [patent_doc_number] => 20130096277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'PROCESSES AND INTERMEDIATES' [patent_app_type] => utility [patent_app_number] => 13/692565 [patent_app_country] => US [patent_app_date] => 2012-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11866 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 48 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13692565 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/692565
PROCESSES AND INTERMEDIATES Dec 2, 2012 Abandoned
Array ( [id] => 10912801 [patent_doc_number] => 20140315818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'METHODS AND PRODUCTS FOR TREATING PREECLAMPSIA AND MODULATING BLOOD PRESSURE' [patent_app_type] => utility [patent_app_number] => 14/362157 [patent_app_country] => US [patent_app_date] => 2012-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15342 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14362157 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/362157
Methods and products for treating preeclampsia and modulating blood pressure Nov 29, 2012 Issued
Array ( [id] => 10912791 [patent_doc_number] => 20140315809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'CALCIMIMETICS AND METHODS FOR THEIR USE' [patent_app_type] => utility [patent_app_number] => 14/357702 [patent_app_country] => US [patent_app_date] => 2012-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22454 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14357702 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/357702
CALCIMIMETICS AND METHODS FOR THEIR USE Nov 11, 2012 Abandoned
Array ( [id] => 8708672 [patent_doc_number] => 20130065961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'MODULATION OF PHYSIOLOGICAL PROCESSES AND AGENTS USEFUL FOR SAME' [patent_app_type] => utility [patent_app_number] => 13/673327 [patent_app_country] => US [patent_app_date] => 2012-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11513 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13673327 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/673327
MODULATION OF PHYSIOLOGICAL PROCESSES AND AGENTS USEFUL FOR SAME Nov 8, 2012 Abandoned
Array ( [id] => 8697996 [patent_doc_number] => 20130060005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-07 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN CFTR AND CAL' [patent_app_type] => utility [patent_app_number] => 13/668388 [patent_app_country] => US [patent_app_date] => 2012-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15156 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13668388 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/668388
COMPOSITIONS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN CFTR AND CAL Nov 4, 2012 Abandoned
Array ( [id] => 10533860 [patent_doc_number] => 09259477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'GLP-1 receptor agonist peptide gastrin conjugates' [patent_app_type] => utility [patent_app_number] => 14/355906 [patent_app_country] => US [patent_app_date] => 2012-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 17506 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355906 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/355906
GLP-1 receptor agonist peptide gastrin conjugates Nov 1, 2012 Issued
Array ( [id] => 10925778 [patent_doc_number] => 20140328799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES' [patent_app_type] => utility [patent_app_number] => 14/355363 [patent_app_country] => US [patent_app_date] => 2012-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12418 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355363 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/355363
COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES Oct 25, 2012 Abandoned
Array ( [id] => 10912813 [patent_doc_number] => 20140315831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'Synthesis of Libraries of Peptide Tertiary Amides' [patent_app_type] => utility [patent_app_number] => 14/354031 [patent_app_country] => US [patent_app_date] => 2012-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16918 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354031 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/354031
Synthesis of libraries of peptide tertiary amides Oct 24, 2012 Issued
Array ( [id] => 9896064 [patent_doc_number] => 20150051262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-19 [patent_title] => 'NMDA RECEPTOR MODULATORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/353681 [patent_app_country] => US [patent_app_date] => 2012-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 55985 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353681 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/353681
NMDA RECEPTOR MODULATORS AND USES THEREOF Oct 23, 2012 Abandoned
Array ( [id] => 9719609 [patent_doc_number] => 20140255309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'Peptide for Synthesizing Silica, and Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/348322 [patent_app_country] => US [patent_app_date] => 2012-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12198 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348322 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/348322
Peptide capable of silica deposition and use thereof Oct 1, 2012 Issued
Array ( [id] => 10953264 [patent_doc_number] => 20140356285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'COMPOSITIONS AND METHODS RELATED TO TISSUE TARGETING' [patent_app_type] => utility [patent_app_number] => 14/346421 [patent_app_country] => US [patent_app_date] => 2012-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32440 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346421 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/346421
COMPOSITIONS AND METHODS RELATED TO TISSUE TARGETING Sep 19, 2012 Abandoned
Array ( [id] => 12305886 [patent_doc_number] => 09938328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-10 [patent_title] => Use of PEDF-derived polypeptides for treating alopecia and/or hair depigmentation [patent_app_type] => utility [patent_app_number] => 14/428843 [patent_app_country] => US [patent_app_date] => 2012-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 10644 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14428843 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/428843
Use of PEDF-derived polypeptides for treating alopecia and/or hair depigmentation Sep 16, 2012 Issued
Array ( [id] => 8612679 [patent_doc_number] => 20130017991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'HCV PROTEASE INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/620573 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 39150 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13620573 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/620573
HCV protease inhibitors and uses thereof Sep 13, 2012 Issued
Array ( [id] => 10968099 [patent_doc_number] => 20140371131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'ADHESIVE BIOPOLYMERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/342392 [patent_app_country] => US [patent_app_date] => 2012-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25729 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342392 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/342392
Adhesive biopolymers and uses thereof Aug 29, 2012 Issued
Array ( [id] => 8523326 [patent_doc_number] => 20120322734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'Pharmaceutical Compositions Including Low Dosages of Desmopressin' [patent_app_type] => utility [patent_app_number] => 13/599768 [patent_app_country] => US [patent_app_date] => 2012-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14242 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13599768 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/599768
Pharmaceutical Compositions Including Low Dosages of Desmopressin Aug 29, 2012 Abandoned
Array ( [id] => 8685294 [patent_doc_number] => 20130053577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'ANTIVIRAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/598430 [patent_app_country] => US [patent_app_date] => 2012-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67145 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13598430 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/598430
Antiviral compounds Aug 28, 2012 Issued
Array ( [id] => 10389775 [patent_doc_number] => 20150274781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'POTENT LIGANDS OF THE GHRELIN RECEPTOR' [patent_app_type] => utility [patent_app_number] => 14/240829 [patent_app_country] => US [patent_app_date] => 2012-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14579 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240829 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/240829
Potent ligands of the ghrelin receptor Aug 23, 2012 Issued
Menu